You are here: Welcome to the MPKB » Welcome to the MPKB » Marshall Protocol » Off-label prescribing of Marshall Protocol medications
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
home:mp:off-label [08.29.2012] – [Off-label prescribing of Marshall Protocol medications] paulalberthome:mp:off-label [09.14.2022] (current) – external edit 127.0.0.1
Line 1: Line 1:
 ====== Off-label prescribing of Marshall Protocol medications  ====== ====== Off-label prescribing of Marshall Protocol medications  ======
  
-Many of the Marshall Protocol (MP) medications are prescribed "off-label", which is to say that they are employed for a purpose outside the drug's approved label. Other countries have different policies, but the US FDA has issued [[http://www.fda.gov/OC/OHRT/IRBS/offlabel.html|clear Policy Guidance]] on off-label prescriptions, clearly stating that it is up to the physician's individual judgment to decide whether an off-label drug should be used.+Many of the Marshall Protocol (MP) medications are prescribed "off-label", which is to say that they are employed for a purpose outside the drug's approved label. Other countries have different policies, but the US FDA has issued [[https://www.fda.gov/OC/OHRT/IRBS/offlabel.html|clear Policy Guidance]] on off-label prescriptions, clearly stating that it is up to the physician's individual judgment to decide whether an off-label drug should be used.
  
 <blockquote>Good medical practice and the best interests of the patient require that physicians use legally available drugs, biologics and devices according to their best knowledge and judgment. If physicians use a product for an indication not in the approved labeling, they have the responsibility to be well-informed about the product, to base its use on firm scientific rationale and on sound medical evidence, and to maintain records of the product's use and effects. Use of a marketed product in this manner __when the intent is the "practice of medicine"__ does not require the submission of an Investigational New Drug Application (IND), an Investigational Device Exemption (IDE) or a review by an Institutional Review Board (IRB). However, the institution at which the product will be used may, under its own authority, require IRB review or other institutional oversight.</blockquote> <blockquote>Good medical practice and the best interests of the patient require that physicians use legally available drugs, biologics and devices according to their best knowledge and judgment. If physicians use a product for an indication not in the approved labeling, they have the responsibility to be well-informed about the product, to base its use on firm scientific rationale and on sound medical evidence, and to maintain records of the product's use and effects. Use of a marketed product in this manner __when the intent is the "practice of medicine"__ does not require the submission of an Investigational New Drug Application (IND), an Investigational Device Exemption (IDE) or a review by an Institutional Review Board (IRB). However, the institution at which the product will be used may, under its own authority, require IRB review or other institutional oversight.</blockquote>
Line 16: Line 16:
 ===== Off-label prescribing is common ======    ===== Off-label prescribing is common ======   
  
-Off-label prescribing is very common.(({{pubmed>long:22507695}})) Almost every physician will prescribe off-label occasionally, most will not even realize it.+Off-label prescribing is very common.(({{pmid>long:22507695}})) Almost every physician will prescribe off-label occasionally, most will not even realize it. 
 + 
 + 
 + 
 +{{tag>MP}}   
 +<nodisp>
 ===== Notes and comments ===== ===== Notes and comments =====
  
Line 22: Line 27:
     *Legacy Content     *Legacy Content
      *      *
-===== References =====+===== References =====</nodisp> 
home/mp/off-label.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.